Philsy
1.1K posts


@Blueberrymgmnt I wondered why she was talking about immunotherapy at the beginning and I am thinking now this will come out at science day. Delivering a STING agonist via pre|CISION® #AVCT storage.googleapis.com/avacta-analysi…
English

Christopher Leidli@chrisleidli
Cancer may be a failure of the immune system. One of the ideas in immunology is that cancer grows because the immune system stops recognizing it. In this podcast episode Dr. Christina Coughlin explains how your immune system is actually designed to find and eliminate cancer cells early. When that system fails — cancer can take hold. 🎧 Learn how immunotherapy is changing cancer treatment in the full episode of Rx for Biotech, streaming now on YouTube and all podcast platforms. #cancer #podcast
QHT

Claude came up with some interesting takes on Avacta. Don’t agree with everything he came up with but certainly agree that the valuation right now is too low. storage.googleapis.com/avacta-analysi…
English

@Timj65 @tom_the_bomb__ Phase 1 trials that result in a total dose limit being completely removed are extremely uncommon. Of course Avacta tech is worthless if you listen to some opinions on here. Today was a massive step forward for the program (not that share price shows it).
English

The FDA has removed the max dosing limit of #AVCT's lead asset. Regulators are extremely conservative about touching it.
Systemic exposure to free dox is now sufficiently controlled.
50 year delivery problem solved ✅
Platform validation ✅
1/2
Avacta@avacta
Avacta has published two key clinical updates to its faridoxorubicin (AVA6000) clinical program. avacta.com/avacta-announc… #AVCT
English

@Cumulus51896691 @grok Why does appointment of Strand Hanson signal preparations for M&A or partnerships?
English

@Paulbritland1 I get paid early this month due to Christmas and will be very happy to scoop up shares at this level. Knowing my luck it will have re-bounded by Friday when people realise they got mugged.
English

@philsy027 My thoughts exactly. People don’t seem to be able to listen/read between the lines. What a great top up opportunity
English

It’s amazing how many still mis-understand Avacta. They are seeing efficacy in an indication which does not normally respond to dox! That is how exquisite the 🎯 of precision platform is! Yet people think the response rates mean Avacta is failing. UK mkt full of muppets. #AVCT
English

@tom_the_bomb__ Yep. Anyone listening to this presentation and selling Avacta at less than 400M MCAP is insane.
English




